Dudley, Mark E.
None,
2024 Rank: 54,150
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,091 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54,150 | 62,926 |
| Total Cites | 1,981 | 2,021 |
| H-index | 23 | 23 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 215 | 217 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 447 | 451 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,269 | 1,279 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.58 |
| Self-Citation Percentage |
1.98%
|
|
Dudley, Mark E.
Novartis International AG,
United States
2023 Rank: 46,238
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,021 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46,238 | 51,410 |
| Total Cites | 2,205 | 2,259 |
| H-index | 25 | 26 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 230 | 236 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 444 | 454 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,339 | 1,359 |
| Ratio of Total Citations to Distinct Citing Papers | 1.65 | 1.66 |
| Self-Citation Percentage |
2.39%
|
|
Dudley, Mark E.
Novartis International AG,
United States
2022 Rank: 26,603
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 721 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26,603 | 29,808 |
| Total Cites | 2,592 | 2,687 |
| H-index | 27 | 27 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 303 | 312 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 589 | 605 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,484 | 1,502 |
| Ratio of Total Citations to Distinct Citing Papers | 1.75 | 1.79 |
| Self-Citation Percentage |
3.54%
|
|
Dudley, Mark E.
Novartis International AG,
United States
2021 Rank: 33,163
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 832 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33,163 | 38,900 |
| Total Cites | 3,914 | 4,009 |
| H-index | 28 | 28 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 465 | 468 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 888 | 900 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,227 | 2,255 |
| Ratio of Total Citations to Distinct Citing Papers | 1.76 | 1.78 |
| Self-Citation Percentage |
2.37%
|
|
Dudley, Mark E.
Novartis International AG,
United States
2020 Rank: 28,647
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 662 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28,647 | 32,735 |
| Total Cites | 3,095 | 3,253 |
| H-index | 26 | 26 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 314 | 327 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 619 | 649 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,710 | 1,749 |
| Ratio of Total Citations to Distinct Citing Papers | 1.81 | 1.86 |
| Self-Citation Percentage |
4.86%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.